nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—pancreatic cancer—adrenal gland cancer	0.313	0.553	CtDrD
Docetaxel—EGFR—adrenal gland cancer	0.259	0.767	CbGaD
Docetaxel—lung cancer—adrenal gland cancer	0.252	0.447	CtDrD
Docetaxel—ABCB1—adrenal gland cancer	0.0788	0.233	CbGaD
Docetaxel—GHRHR—pituitary gland—adrenal gland cancer	0.00205	0.0684	CbGeAlD
Docetaxel—KIF11—adrenal gland—adrenal gland cancer	0.00155	0.0519	CbGeAlD
Docetaxel—MAPT—pituitary gland—adrenal gland cancer	0.00102	0.0341	CbGeAlD
Docetaxel—MAPT—adrenal gland—adrenal gland cancer	0.000911	0.0304	CbGeAlD
Docetaxel—MAP4—gonad—adrenal gland cancer	0.000822	0.0275	CbGeAlD
Docetaxel—MAP2—adrenal cortex—adrenal gland cancer	0.000781	0.0261	CbGeAlD
Docetaxel—BCL2—gonad—adrenal gland cancer	0.000747	0.025	CbGeAlD
Docetaxel—CYP3A4—urine—adrenal gland cancer	0.000731	0.0244	CbGeAlD
Docetaxel—MAP4—adrenal gland—adrenal gland cancer	0.000716	0.0239	CbGeAlD
Docetaxel—SLCO1B3—pituitary gland—adrenal gland cancer	0.000702	0.0235	CbGeAlD
Docetaxel—Cabazitaxel—ABCB1—adrenal gland cancer	0.000695	0.553	CrCbGaD
Docetaxel—MAP2—gonad—adrenal gland cancer	0.000647	0.0216	CbGeAlD
Docetaxel—MAP2—cardiac atrium—adrenal gland cancer	0.000646	0.0216	CbGeAlD
Docetaxel—EGFR—adrenal gland—adrenal gland cancer	0.000643	0.0215	CbGeAlD
Docetaxel—MAP2—pituitary gland—adrenal gland cancer	0.000631	0.0211	CbGeAlD
Docetaxel—TUBB4A—adrenal cortex—adrenal gland cancer	0.000604	0.0202	CbGeAlD
Docetaxel—MAP2—adrenal gland—adrenal gland cancer	0.000564	0.0188	CbGeAlD
Docetaxel—Paclitaxel—ABCB1—adrenal gland cancer	0.000562	0.447	CrCbGaD
Docetaxel—TUBB—adrenal cortex—adrenal gland cancer	0.000552	0.0185	CbGeAlD
Docetaxel—TUBB2A—adrenal cortex—adrenal gland cancer	0.000549	0.0184	CbGeAlD
Docetaxel—TUBB6—adrenal cortex—adrenal gland cancer	0.000542	0.0181	CbGeAlD
Docetaxel—TUBB4A—gonad—adrenal gland cancer	0.0005	0.0167	CbGeAlD
Docetaxel—TUBB2B—gonad—adrenal gland cancer	0.000483	0.0162	CbGeAlD
Docetaxel—TUBB2B—cardiac atrium—adrenal gland cancer	0.000483	0.0161	CbGeAlD
Docetaxel—ABCC10—adrenal cortex—adrenal gland cancer	0.000474	0.0159	CbGeAlD
Docetaxel—TUBB2B—pituitary gland—adrenal gland cancer	0.000472	0.0158	CbGeAlD
Docetaxel—TUBB4B—adrenal cortex—adrenal gland cancer	0.000471	0.0157	CbGeAlD
Docetaxel—TUBB—cardiac atrium—adrenal gland cancer	0.000457	0.0153	CbGeAlD
Docetaxel—TUBB2A—cardiac atrium—adrenal gland cancer	0.000454	0.0152	CbGeAlD
Docetaxel—TUBB6—gonad—adrenal gland cancer	0.000449	0.015	CbGeAlD
Docetaxel—TUBB6—cardiac atrium—adrenal gland cancer	0.000448	0.015	CbGeAlD
Docetaxel—TUBB—pituitary gland—adrenal gland cancer	0.000446	0.0149	CbGeAlD
Docetaxel—TUBB2A—pituitary gland—adrenal gland cancer	0.000444	0.0148	CbGeAlD
Docetaxel—TUBB6—pituitary gland—adrenal gland cancer	0.000438	0.0146	CbGeAlD
Docetaxel—TUBB4A—adrenal gland—adrenal gland cancer	0.000436	0.0146	CbGeAlD
Docetaxel—TUBB2B—adrenal gland—adrenal gland cancer	0.000421	0.0141	CbGeAlD
Docetaxel—TUBB—adrenal gland—adrenal gland cancer	0.000399	0.0133	CbGeAlD
Docetaxel—TUBB2A—adrenal gland—adrenal gland cancer	0.000397	0.0133	CbGeAlD
Docetaxel—ABCC10—gonad—adrenal gland cancer	0.000393	0.0131	CbGeAlD
Docetaxel—ABCC10—cardiac atrium—adrenal gland cancer	0.000392	0.0131	CbGeAlD
Docetaxel—TUBB6—adrenal gland—adrenal gland cancer	0.000391	0.0131	CbGeAlD
Docetaxel—TUBB4B—gonad—adrenal gland cancer	0.00039	0.013	CbGeAlD
Docetaxel—TUBB4B—cardiac atrium—adrenal gland cancer	0.00039	0.013	CbGeAlD
Docetaxel—ABCC10—pituitary gland—adrenal gland cancer	0.000383	0.0128	CbGeAlD
Docetaxel—TUBB4B—pituitary gland—adrenal gland cancer	0.000381	0.0127	CbGeAlD
Docetaxel—ABCC10—adrenal gland—adrenal gland cancer	0.000342	0.0114	CbGeAlD
Docetaxel—TUBB4B—adrenal gland—adrenal gland cancer	0.00034	0.0114	CbGeAlD
Docetaxel—ABCC1—adrenal cortex—adrenal gland cancer	0.000336	0.0112	CbGeAlD
Docetaxel—CYP1B1—gonad—adrenal gland cancer	0.000309	0.0103	CbGeAlD
Docetaxel—CYP1B1—pituitary gland—adrenal gland cancer	0.000301	0.0101	CbGeAlD
Docetaxel—ABCG2—adrenal cortex—adrenal gland cancer	0.000278	0.00928	CbGeAlD
Docetaxel—ABCC1—cardiac atrium—adrenal gland cancer	0.000278	0.00927	CbGeAlD
Docetaxel—ABCC2—adrenal gland—adrenal gland cancer	0.000275	0.00919	CbGeAlD
Docetaxel—ABCC1—pituitary gland—adrenal gland cancer	0.000271	0.00906	CbGeAlD
Docetaxel—CYP1B1—adrenal gland—adrenal gland cancer	0.000269	0.009	CbGeAlD
Docetaxel—ABCC1—adrenal gland—adrenal gland cancer	0.000242	0.00809	CbGeAlD
Docetaxel—ABCG2—pituitary gland—adrenal gland cancer	0.000224	0.0075	CbGeAlD
Docetaxel—ABCG2—adrenal gland—adrenal gland cancer	0.000201	0.0067	CbGeAlD
Docetaxel—ABCB1—adrenal cortex—adrenal gland cancer	0.000137	0.00458	CbGeAlD
Docetaxel—ABCB1—gonad—adrenal gland cancer	0.000113	0.00379	CbGeAlD
Docetaxel—ABCB1—pituitary gland—adrenal gland cancer	0.000111	0.0037	CbGeAlD
Docetaxel—ABCB1—adrenal gland—adrenal gland cancer	9.89e-05	0.0033	CbGeAlD
Docetaxel—EGFR—MAPK Signaling Pathway—BRAF—adrenal gland cancer	3.33e-05	0.000503	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—IGF2—adrenal gland cancer	3.33e-05	0.000503	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.32e-05	0.000502	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—BAD—adrenal gland cancer	3.32e-05	0.000501	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CDC42—adrenal gland cancer	3.31e-05	0.000499	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	3.3e-05	0.000499	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.28e-05	0.000495	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.26e-05	0.000493	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SH3KBP1—adrenal gland cancer	3.26e-05	0.000492	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TERT—adrenal gland cancer	3.25e-05	0.000491	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—BAD—adrenal gland cancer	3.25e-05	0.000491	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.2e-05	0.000483	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	3.2e-05	0.000483	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—BRAF—adrenal gland cancer	3.2e-05	0.000483	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SH3KBP1—adrenal gland cancer	3.19e-05	0.000482	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SDHB—adrenal gland cancer	3.14e-05	0.000475	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—RB1—adrenal gland cancer	3.14e-05	0.000474	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—TP53—adrenal gland cancer	3.13e-05	0.000474	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	3.11e-05	0.00047	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—CDC42—adrenal gland cancer	3.1e-05	0.000469	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	3.06e-05	0.000463	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SDHB—adrenal gland cancer	3.04e-05	0.000459	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—BRAF—adrenal gland cancer	3.02e-05	0.000456	CbGpPWpGaD
Docetaxel—EGFR—Disease—SH3KBP1—adrenal gland cancer	3.01e-05	0.000454	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ZNRF3—adrenal gland cancer	3e-05	0.000453	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—IGF2—adrenal gland cancer	2.99e-05	0.000452	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TERT—adrenal gland cancer	2.98e-05	0.000451	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.98e-05	0.000451	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	2.95e-05	0.000446	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.93e-05	0.000442	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—EGFR—adrenal gland cancer	2.92e-05	0.000442	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.91e-05	0.00044	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—adrenal gland cancer	2.89e-05	0.000437	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—SDHD—adrenal gland cancer	2.86e-05	0.000433	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—RRM1—adrenal gland cancer	2.86e-05	0.000433	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—TP53—adrenal gland cancer	2.84e-05	0.00043	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.84e-05	0.000429	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	2.83e-05	0.000428	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—BAD—adrenal gland cancer	2.83e-05	0.000427	CbGpPWpGaD
Docetaxel—EGFR—Disease—ZNRF3—adrenal gland cancer	2.83e-05	0.000427	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—RB1—adrenal gland cancer	2.8e-05	0.000424	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.78e-05	0.000421	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SDHB—adrenal gland cancer	2.76e-05	0.000418	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	2.76e-05	0.000416	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SDHB—adrenal gland cancer	2.74e-05	0.000414	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—IGF2—adrenal gland cancer	2.73e-05	0.000413	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TERT—adrenal gland cancer	2.73e-05	0.000412	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.69e-05	0.000407	CbGpPWpGaD
Docetaxel—KIF11—Immune System—EGFR—adrenal gland cancer	2.68e-05	0.000405	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.64e-05	0.0004	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	2.62e-05	0.000396	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—POMC—adrenal gland cancer	2.61e-05	0.000394	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	2.6e-05	0.000392	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—BRAF—adrenal gland cancer	2.57e-05	0.000389	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—EGFR—adrenal gland cancer	2.49e-05	0.000377	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.47e-05	0.000373	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—CDKN2A—adrenal gland cancer	2.46e-05	0.000372	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.45e-05	0.000369	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—POMC—adrenal gland cancer	2.43e-05	0.000367	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—POMC—adrenal gland cancer	2.43e-05	0.000367	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	2.43e-05	0.000367	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—BAD—adrenal gland cancer	2.39e-05	0.000361	CbGpPWpGaD
Docetaxel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	2.39e-05	0.000361	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.39e-05	0.000361	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.38e-05	0.000359	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—RB1—adrenal gland cancer	2.38e-05	0.000359	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.35e-05	0.000355	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—POMC—adrenal gland cancer	2.35e-05	0.000355	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—RB1—adrenal gland cancer	2.32e-05	0.000351	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—BAD—adrenal gland cancer	2.31e-05	0.000349	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PRKACA—adrenal gland cancer	2.3e-05	0.000348	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GNRH1—adrenal gland cancer	2.3e-05	0.000347	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	2.28e-05	0.000345	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—POMC—adrenal gland cancer	2.27e-05	0.000343	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PRKACA—adrenal gland cancer	2.27e-05	0.000343	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNRHR—adrenal gland cancer	2.26e-05	0.000342	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—POMC—adrenal gland cancer	2.22e-05	0.000336	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	2.21e-05	0.000335	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CDC42—adrenal gland cancer	2.21e-05	0.000334	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PRKACA—adrenal gland cancer	2.21e-05	0.000334	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—CTNNB1—adrenal gland cancer	2.18e-05	0.00033	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—BRAF—adrenal gland cancer	2.18e-05	0.000329	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.17e-05	0.000328	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—MED12—adrenal gland cancer	2.13e-05	0.000323	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—adrenal gland cancer	2.12e-05	0.000321	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—RB1—adrenal gland cancer	2.12e-05	0.000321	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SH3KBP1—adrenal gland cancer	2.1e-05	0.000318	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	2.09e-05	0.000316	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.07e-05	0.000312	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TSHR—adrenal gland cancer	2.05e-05	0.000309	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CDKN2A—adrenal gland cancer	2.04e-05	0.000308	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—RRM1—adrenal gland cancer	2.02e-05	0.000306	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SDHD—adrenal gland cancer	2.02e-05	0.000306	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—POMC—adrenal gland cancer	2e-05	0.000301	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SDHB—adrenal gland cancer	1.98e-05	0.000299	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ZNRF3—adrenal gland cancer	1.98e-05	0.000299	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SDHD—adrenal gland cancer	1.96e-05	0.000296	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—RRM1—adrenal gland cancer	1.96e-05	0.000296	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CDC42—adrenal gland cancer	1.95e-05	0.000295	CbGpPWpGaD
Docetaxel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.94e-05	0.000293	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.93e-05	0.000291	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDC42—adrenal gland cancer	1.93e-05	0.000291	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.91e-05	0.000288	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.91e-05	0.000288	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.89e-05	0.000286	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SPRY2—adrenal gland cancer	1.88e-05	0.000284	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDC42—adrenal gland cancer	1.88e-05	0.000284	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.87e-05	0.000282	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CDKN2A—adrenal gland cancer	1.87e-05	0.000282	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CTNNB1—adrenal gland cancer	1.86e-05	0.000281	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—adrenal gland cancer	1.85e-05	0.00028	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—POMC—adrenal gland cancer	1.82e-05	0.000276	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SDHD—adrenal gland cancer	1.78e-05	0.000269	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—RRM1—adrenal gland cancer	1.78e-05	0.000269	CbGpPWpGaD
Docetaxel—EGFR—Disease—SPRY2—adrenal gland cancer	1.77e-05	0.000268	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—RRM1—adrenal gland cancer	1.77e-05	0.000267	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SDHD—adrenal gland cancer	1.77e-05	0.000267	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	1.74e-05	0.000264	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CTNNB1—adrenal gland cancer	1.73e-05	0.000262	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CTNNB1—adrenal gland cancer	1.73e-05	0.000262	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MEN1—adrenal gland cancer	1.72e-05	0.00026	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.68e-05	0.000253	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CTNNB1—adrenal gland cancer	1.67e-05	0.000253	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.67e-05	0.000252	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.64e-05	0.000249	CbGpPWpGaD
Docetaxel—EGFR—Disease—MEN1—adrenal gland cancer	1.62e-05	0.000245	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CTNNB1—adrenal gland cancer	1.62e-05	0.000245	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—adrenal gland cancer	1.6e-05	0.000242	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CTNNB1—adrenal gland cancer	1.59e-05	0.00024	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PRKACA—adrenal gland cancer	1.56e-05	0.000235	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.52e-05	0.00023	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CTNNB1—adrenal gland cancer	1.52e-05	0.000229	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MED12—adrenal gland cancer	1.51e-05	0.000228	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SDHB—adrenal gland cancer	1.49e-05	0.000226	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—adrenal gland cancer	1.47e-05	0.000223	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PRKACA—adrenal gland cancer	1.47e-05	0.000222	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MED12—adrenal gland cancer	1.46e-05	0.000221	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.45e-05	0.000218	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CTNNB1—adrenal gland cancer	1.42e-05	0.000215	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—adrenal gland cancer	1.37e-05	0.000207	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—BAD—adrenal gland cancer	1.36e-05	0.000206	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNRH1—adrenal gland cancer	1.36e-05	0.000205	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.35e-05	0.000204	CbGpPWpGaD
Docetaxel—BCL2—Immune System—BAD—adrenal gland cancer	1.34e-05	0.000203	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PRKACA—adrenal gland cancer	1.34e-05	0.000203	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MED12—adrenal gland cancer	1.33e-05	0.000201	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MED12—adrenal gland cancer	1.32e-05	0.000199	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PRKACA—adrenal gland cancer	1.31e-05	0.000199	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—BAD—adrenal gland cancer	1.31e-05	0.000198	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.3e-05	0.000197	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CTNNB1—adrenal gland cancer	1.3e-05	0.000197	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SDHD—adrenal gland cancer	1.28e-05	0.000193	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—RRM1—adrenal gland cancer	1.28e-05	0.000193	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GNAS—adrenal gland cancer	1.26e-05	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CDC42—adrenal gland cancer	1.25e-05	0.000188	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SPRY2—adrenal gland cancer	1.24e-05	0.000187	CbGpPWpGaD
Docetaxel—EGFR—Disease—PRKACA—adrenal gland cancer	1.24e-05	0.000187	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ABCB1—adrenal gland cancer	1.24e-05	0.000187	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—adrenal gland cancer	1.24e-05	0.000187	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.23e-05	0.000185	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TSHR—adrenal gland cancer	1.21e-05	0.000183	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—adrenal gland cancer	1.2e-05	0.000182	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GNAS—adrenal gland cancer	1.19e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDC42—adrenal gland cancer	1.14e-05	0.000172	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MEN1—adrenal gland cancer	1.14e-05	0.000172	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—adrenal gland cancer	1.14e-05	0.000172	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.12e-05	0.000169	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDC42—adrenal gland cancer	1.12e-05	0.000168	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PRKACA—adrenal gland cancer	1.1e-05	0.000166	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.1e-05	0.000166	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.08e-05	0.000163	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PRKACA—adrenal gland cancer	1.06e-05	0.000161	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDC42—adrenal gland cancer	1.05e-05	0.000159	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.04e-05	0.000157	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—adrenal gland cancer	1.04e-05	0.000157	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	1.03e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CTNNB1—adrenal gland cancer	1.02e-05	0.000154	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PRKACA—adrenal gland cancer	9.69e-06	0.000146	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SDHD—adrenal gland cancer	9.63e-06	0.000145	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—RRM1—adrenal gland cancer	9.63e-06	0.000145	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	9.6e-06	0.000145	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MED12—adrenal gland cancer	9.51e-06	0.000144	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SDHB—adrenal gland cancer	9.21e-06	0.000139	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	9.06e-06	0.000137	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—adrenal gland cancer	8.97e-06	0.000136	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TERT—adrenal gland cancer	8.94e-06	0.000135	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GNAS—adrenal gland cancer	8.92e-06	0.000135	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—adrenal gland cancer	8.84e-06	0.000134	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ABCB1—adrenal gland cancer	8.76e-06	0.000132	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	8.69e-06	0.000131	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRKACA—adrenal gland cancer	8.68e-06	0.000131	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GNAS—adrenal gland cancer	8.63e-06	0.00013	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—POMC—adrenal gland cancer	8.5e-06	0.000128	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ABCB1—adrenal gland cancer	8.47e-06	0.000128	CbGpPWpGaD
Docetaxel—EGFR—Disease—TERT—adrenal gland cancer	8.43e-06	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—POMC—adrenal gland cancer	8.02e-06	0.000121	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BAD—adrenal gland cancer	7.94e-06	0.00012	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GNAS—adrenal gland cancer	7.85e-06	0.000119	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GNAS—adrenal gland cancer	7.78e-06	0.000118	CbGpPWpGaD
Docetaxel—ABCC1—Disease—BAD—adrenal gland cancer	7.78e-06	0.000118	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ABCB1—adrenal gland cancer	7.7e-06	0.000116	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	7.64e-06	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDC42—adrenal gland cancer	7.36e-06	0.000111	CbGpPWpGaD
Docetaxel—EGFR—Disease—BAD—adrenal gland cancer	7.33e-06	0.000111	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	7.3e-06	0.00011	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MED12—adrenal gland cancer	7.18e-06	0.000108	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF2—adrenal gland cancer	7.09e-06	0.000107	CbGpPWpGaD
Docetaxel—ABCC1—Disease—BRAF—adrenal gland cancer	7.08e-06	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GNAS—adrenal gland cancer	7.03e-06	0.000106	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—adrenal gland cancer	7e-06	0.000106	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	6.94e-06	0.000105	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1R—adrenal gland cancer	6.86e-06	0.000104	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—adrenal gland cancer	6.78e-06	0.000102	CbGpPWpGaD
Docetaxel—EGFR—Disease—BRAF—adrenal gland cancer	6.68e-06	0.000101	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—POMC—adrenal gland cancer	6.01e-06	9.08e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SDHD—adrenal gland cancer	5.93e-06	8.96e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RRM1—adrenal gland cancer	5.93e-06	8.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—adrenal gland cancer	5.9e-06	8.92e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—POMC—adrenal gland cancer	5.81e-06	8.78e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—adrenal gland cancer	5.72e-06	8.65e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GNAS—adrenal gland cancer	5.63e-06	8.5e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	5.52e-06	8.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—adrenal gland cancer	5.39e-06	8.15e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—POMC—adrenal gland cancer	5.29e-06	7.99e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—POMC—adrenal gland cancer	5.24e-06	7.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PRKACA—adrenal gland cancer	5.24e-06	7.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—adrenal gland cancer	5.23e-06	7.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BAD—adrenal gland cancer	5.14e-06	7.76e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—adrenal gland cancer	5.12e-06	7.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—adrenal gland cancer	4.83e-06	7.29e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—adrenal gland cancer	4.79e-06	7.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—POMC—adrenal gland cancer	4.73e-06	7.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BRAF—adrenal gland cancer	4.68e-06	7.06e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—adrenal gland cancer	4.63e-06	7e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MED12—adrenal gland cancer	4.42e-06	6.68e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNAS—adrenal gland cancer	4.24e-06	6.41e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—adrenal gland cancer	4.22e-06	6.37e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	4.18e-06	6.31e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—adrenal gland cancer	4.06e-06	6.13e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—POMC—adrenal gland cancer	3.79e-06	5.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—adrenal gland cancer	3.38e-06	5.11e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	3.23e-06	4.88e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	3.02e-06	4.56e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—POMC—adrenal gland cancer	2.86e-06	4.32e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNAS—adrenal gland cancer	2.62e-06	3.95e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	2.57e-06	3.88e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—adrenal gland cancer	2.28e-06	3.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—adrenal gland cancer	2.25e-06	3.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.76e-06	2.66e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	1.4e-06	2.12e-05	CbGpPWpGaD
